Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem (Estradiol) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites.

NCT00426972 is registered in ClinicalTrials.gov with Renovo as lead sponsor.

NCT NCT00426972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00426972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem (Estradiol) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites.
Lead sponsor
Renovo
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2008
Enrollment
148 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

burn, trauma, varicose ulcer